The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research […]
This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium was looking for a novel antibiotic compound to progress to a clinical candidate […]
This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also […]
GNA NOW Open Call webinar II This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative’s GNA NOW Consortium was looking for a novel antibiotic compound […]
About twenty people attended this webinar which focused on TB research within the IMI AMR Accelerator. During the first part of this TB research focused webinar, Martin Boeree (UNITE4TB and […]
The 2nd Annual meeting for the Cross-IMI AMR Accelerator community was held online on 28 September 2021 and brought together >160 members of the 8 AMR Accelerator projects. After an […]
Recap of the first UNITE4TB webinar: Panel discussion on global burden of TB On 03 March 2022, UNITE4TB held its first in a series of webinars being organized by project […]
About fifteen people attended this webinar which provided the most recent updates of ongoing TB research within the IMI AMR Accelerator. The following speakers addressed the challenges of their respective […]
The 3rd AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9 projects, took place on 06 April 2022 in Basel, Switzerland. Please find more details here […]
In June 2022, the Paul-Ehrlich-Institut organised a two-day virtual expert workshop on behalf of the COMBINE project. The workshop aimed to address the challenges in developing monoclonal antibodies (mAbs) against […]